Literature DB >> 2442997

Ultrastructural, histochemical, and freeze-fracture evaluation of multilamellated structures in human pulmonary alveolar proteinosis.

T Takemura, Y Fukuda, M Harrison, V J Ferrans.   

Abstract

Ultrastructural, histochemical, and freeze-fracture studies of material recovered by bronchoalveolar lavage from patients with pulmonary alveolar proteinosis revealed four types (A, B, C, and D) of multilamellated structures (MS). Type A, the major component, consisted of concentric, trilaminar structures which were composed of two electron-dense layers and a central lucent layer (5.7-7.5 nm in overall width) alternating with wider (25-30 nm) electron-lucent intervening layers. Type B MS were formed by concentric lamellae with a 5-5.3-nm periodicity. Type C MS were composed of wavy, electron-dense lamellae with a 4-4.5-nm periodicity. Type D MS were conglomerated masses of intricately arranged double or triple electron-dense layers (7.5-13.5 nm wide) alternating with wider (30-40-nm) electron-lucent layers. The electron-dense lamellae of type A, type C, and type D MS were stained with ruthenium red, the Thiéry method, and concanavalin A, indicating the presence of carbohydrate components. Freeze-fracture studies revealed smooth inner and outer surfaces in type A MS, with the fracture planes passing through the central parts of the trilaminar structures; the intervening layers contained 10-nm particles, which probably are proteins. Type B MS had smooth surfaces, and type C MS had slightly particulate surfaces; while type D MS showed tubular or polygonal structures, 350 nm wide, with rows of particles 7-8 nm in diameter. It is concluded that type A and type D MS contain proteins and carbohydrates, probably in the form of glycoproteins, as well as phospholipids, and are related to tubular myelin. Type B and type C MS are considered to contain mainly phospholipids; type C MS are also considered to contain carbohydrates and to be related to lamellar bodies of type II alveolar epithelial cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2442997     DOI: 10.1002/aja.1001790307

Source DB:  PubMed          Journal:  Am J Anat        ISSN: 0002-9106


  7 in total

Review 1.  Pulmonary alveolar proteinosis: clinical aspects and current concepts on pathogenesis.

Authors:  P L Shah; D Hansell; P R Lawson; K B Reid; C Morgan
Journal:  Thorax       Date:  2000-01       Impact factor: 9.139

2.  Lamellar body ultrastructure revisited: high-pressure freezing and cryo-electron microscopy of vitreous sections.

Authors:  Dimitri Vanhecke; Gudrun Herrmann; Werner Graber; Therese Hillmann-Marti; Christian Mühlfeld; Daniel Studer; Matthias Ochs
Journal:  Histochem Cell Biol       Date:  2010-09-01       Impact factor: 4.304

Review 3.  An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy.

Authors:  Geoffrey Kurland; Robin R Deterding; James S Hagood; Lisa R Young; Alan S Brody; Robert G Castile; Sharon Dell; Leland L Fan; Aaron Hamvas; Bettina C Hilman; Claire Langston; Lawrence M Nogee; Gregory J Redding
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

4.  Pulmonary alveolar proteinosis: diagnosis using routinely processed smears of bronchoalveolar lavage fluid.

Authors:  T Mikami; Y Yamamoto; M Yokoyama; I Okayasu
Journal:  J Clin Pathol       Date:  1997-12       Impact factor: 3.411

5.  Surfactant protein D. Increased accumulation in silica-induced pulmonary lipoproteinosis.

Authors:  E Crouch; A Persson; D Chang; D Parghi
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

6.  Accumulation of surfactant protein D in human pulmonary alveolar proteinosis.

Authors:  E Crouch; A Persson; D Chang
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

7.  Cytopathological examination of bronchoalveolar lavage fluid in diagnosis of pulmonary alveolar proteinosis.

Authors:  Manjari Kishore; Manju Kaushal; Desh Deepak; Manju Kumari
Journal:  J Lab Physicians       Date:  2018 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.